BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 20033712)

  • 1. Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer.
    Choi J; Kim SG; Kim JS; Jung HC; Song IS
    Surg Endosc; 2010 Jun; 24(6):1380-6. PubMed ID: 20033712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.
    Pfau PR; Perlman SB; Stanko P; Frick TJ; Gopal DV; Said A; Zhang Z; Weigel T
    Gastrointest Endosc; 2007 Mar; 65(3):377-84. PubMed ID: 17321235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.
    Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP
    Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implication of PET/MR imaging in preoperative esophageal cancer staging: comparison with PET/CT, endoscopic ultrasonography, and CT.
    Lee G; I H; Kim SJ; Jeong YJ; Kim IJ; Pak K; Park DY; Kim GH
    J Nucl Med; 2014 Aug; 55(8):1242-7. PubMed ID: 24868109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography, and EUS.
    Sandha GS; Severin D; Postema E; McEwan A; Stewart K
    Gastrointest Endosc; 2008 Mar; 67(3):402-9. PubMed ID: 18178202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.
    Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of preoperative staging for a priori resectable esophageal cancer.
    Winiker M; Mantziari S; Figueiredo SG; Demartines N; Allemann P; Schäfer M
    Dis Esophagus; 2018 Jan; 31(1):1-6. PubMed ID: 29346598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic ultrasonography in esophageal cancer leads to improved survival rates: results from a population-based study.
    Wani S; Das A; Rastogi A; Drahos J; Ricker W; Parsons R; Bansal A; Yen R; Hosford L; Jankowski M; Sharma P; Cook MB
    Cancer; 2015 Jan; 121(2):194-201. PubMed ID: 25236485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic ultrasound staging for early esophageal cancer: Are we denying patients neoadjuvant chemo-radiation?
    Luu C; Amaral M; Klapman J; Harris C; Almhanna K; Hoffe S; Frakes J; Pimiento JM; Fontaine JP
    World J Gastroenterol; 2017 Dec; 23(46):8193-8199. PubMed ID: 29290655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?
    Schreurs LM; Janssens AC; Groen H; Fockens P; van Dullemen HM; van Berge Henegouwen MI; Sloof GW; Pruim J; van Lanschot JJ; Steyerberg EW; Plukker JT
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1021-1028. PubMed ID: 21547703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer.
    Omloo JM; Sloof GW; Boellaard R; Hoekstra OS; Jager PL; van Dullemen HM; Fockens P; Plukker JT; van Lanschot JJ
    Endoscopy; 2008 Jun; 40(6):464-71. PubMed ID: 18543134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node staging in esophageal squamous cell carcinoma: a comparative study of endoscopic ultrasonography versus computed tomography.
    Takizawa K; Matsuda T; Kozu T; Eguchi T; Kato H; Nakanishi Y; Hijikata A; Saito D
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1687-91. PubMed ID: 19788609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective analysis of the diagnostic accuracy of 3 T MRI, CT and endoscopic ultrasound for preoperative T staging of potentially resectable esophageal cancer.
    Guo J; Wang Z; Qin J; Zhang H; Liu W; Zhao Y; Lu Y; Yan X; Zhang Z; Zhang T; Zhang S; Dominik NM; Kamel IR; Li H; Qu J
    Cancer Imaging; 2020 Sep; 20(1):64. PubMed ID: 32912319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appraisal of staging endoscopic ultrasonography in a modern high-volume esophageal program.
    O'Farrell NJ; Malik V; Donohoe CL; Johnston C; Muldoon C; Reynolds JV; O'Toole D
    World J Surg; 2013 Jul; 37(7):1666-72. PubMed ID: 23568244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparison of MR with diffusion-weighted imaging, endoscopic ultrasound, MDCT and positron emission tomography-CT in the pre-operative staging of oesophageal cancer: results from a pilot study.
    Giganti F; Ambrosi A; Petrone MC; Canevari C; Chiari D; Salerno A; Arcidiacono PG; Nicoletti R; Albarello L; Mazza E; Gallivanone F; Gianolli L; Orsenigo E; Esposito A; Staudacher C; Del Maschio A; De Cobelli F
    Br J Radiol; 2016 Dec; 89(1068):20160087. PubMed ID: 27767330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low impact of staging EUS for determining surgical resectability in esophageal cancer.
    van Zoonen M; van Oijen MG; van Leeuwen MS; van Hillegersberg R; Siersema PD; Vleggaar FP
    Surg Endosc; 2012 Oct; 26(10):2828-34. PubMed ID: 22692460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenocarcinoma of the esophagus and the esophagogastric junction: positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease.
    Sihvo EI; Räsänen JV; Knuuti MJ; Minn HR; Luostarinen ME; Viljanen T; Färkkilä MA; Salo JA
    J Gastrointest Surg; 2004 Dec; 8(8):988-96. PubMed ID: 15585386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple staging investigations may not change management in patients with high-grade dysplasia or early esophageal adenocarcinoma.
    Reyhani A; Gimson E; Baker C; Kelly M; Maisey N; Meenan J; Subesinghe M; Hill M; Lagergren J; Gossage J; Zeki S; Dunn J; Davies A
    Dis Esophagus; 2023 Sep; 36(10):. PubMed ID: 37032121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgically resected T1- and T2-stage esophageal squamous cell carcinoma: T and N staging performance of EUS and PET/CT.
    Jeong DY; Kim MY; Lee KS; Choi JY; Kim SJ; Chung MJ; Min YW; Kim HK; Zo JI; Shim YM; Sun JM
    Cancer Med; 2018 Aug; 7(8):3561-3570. PubMed ID: 29932307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.